Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Zoccoli

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Human Immunology|May 14, 2011
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control studySara Galluzzo, Giuseppe Patti, Giordano Dicuonzo, et al.
Scientific Reports|January 30, 2020
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerFrancesco Pantano, Elisabetta Rossi, Michele Iuliani, et al.
Expert Opinion on Therapeutic Targets|March 27, 2012
Premetastatic niche: ready for new therapeutic interventions?Alice Zoccoli, Michele Iuliani, Francesco Pantano, et al.
Expert Opinion on Emerging Drugs|June 27, 2015
Emerging drugs for the treatment of bone metastasisFrancesco Pantano, Michele Iuliani, Alice Zoccoli, et al.
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
Targeting EGFR in bilio-pancreatic and liver carcinomaMaria Elisabetta Fratto, Daniele Santini, Bruno Vincenzi, et al.
Plos One|November 19, 2013
The synergistic effect of everolimus and chloroquine on endothelial cell number reduction is paralleled by increased apoptosis and reduced autophagy occurrenceAnna Grimaldi, Maria Luisa Balestrieri, Nunzia D'Onofrio, et al.
Biochimica Et Biophysica Acta|February 1, 2014
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinomaMatteo Santoni, Francesco Pantano, Consuelo Amantini, et al.
Breast Cancer Research : BCR|September 3, 2015
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidenceDaniele Santini, Luciano Stumbo, Chiara Spoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Should oncologists be aware in their clinical practice of KRAS molecular analysis?Daniele Santini, Sara Galluzzo, Laura Gaeta, et al.
British Journal of Pharmacology|May 7, 2021
Therapeutic strategies to fight COVID-19: Which is the status artis?Cristina Scavone, Annamaria Mascolo, Concetta Rafaniello, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Human Immunology|May 14, 2011
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control studySara Galluzzo, Giuseppe Patti, Giordano Dicuonzo, et al.
Scientific Reports|January 30, 2020
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerFrancesco Pantano, Elisabetta Rossi, Michele Iuliani, et al.
Expert Opinion on Therapeutic Targets|March 27, 2012
Premetastatic niche: ready for new therapeutic interventions?Alice Zoccoli, Michele Iuliani, Francesco Pantano, et al.
Expert Opinion on Emerging Drugs|June 27, 2015
Emerging drugs for the treatment of bone metastasisFrancesco Pantano, Michele Iuliani, Alice Zoccoli, et al.
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
Targeting EGFR in bilio-pancreatic and liver carcinomaMaria Elisabetta Fratto, Daniele Santini, Bruno Vincenzi, et al.
Plos One|November 19, 2013
The synergistic effect of everolimus and chloroquine on endothelial cell number reduction is paralleled by increased apoptosis and reduced autophagy occurrenceAnna Grimaldi, Maria Luisa Balestrieri, Nunzia D'Onofrio, et al.
Biochimica Et Biophysica Acta|February 1, 2014
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinomaMatteo Santoni, Francesco Pantano, Consuelo Amantini, et al.
Breast Cancer Research : BCR|September 3, 2015
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidenceDaniele Santini, Luciano Stumbo, Chiara Spoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Should oncologists be aware in their clinical practice of KRAS molecular analysis?Daniele Santini, Sara Galluzzo, Laura Gaeta, et al.
British Journal of Pharmacology|May 7, 2021
Therapeutic strategies to fight COVID-19: Which is the status artis?Cristina Scavone, Annamaria Mascolo, Concetta Rafaniello, et al.
Pageof 3